Biological mechanisms underlying the relationship between stress and smoking: State of the science and directions for future work

Biological Psychology

Volumn 88, Issue 1, 2011, Pages 1-12

  Richards, Jessica M ^a   Stipelman, Brooke A ^b   Bornovalova, Marina A ^c   Daughters, Stacey B ^d   Sinha, Rajita ^e,f   Lejuez, C W ^a,f  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic nervous system; Cortisol; HPA axis; Nicotine dependence; Smoking; Stress

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NICOTINE;

AUTONOMIC NERVOUS SYSTEM; CIGARETTE SMOKING; DISEASE COURSE; DRUG SEEKING BEHAVIOR; GENDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INDIVIDUALIZATION; MENTAL DISEASE; MENTAL STRESS; MOTIVATION; NONHUMAN; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REVIEW; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE;

AUTONOMIC NERVOUS SYSTEM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NICOTINE; PITUITARY-ADRENAL SYSTEM; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 80052471044     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2011.06.009     Document Type: Review

References (170)

1. Adamopoulos D., van de Borne P., Argacha J.F. New insights into the sympathetic, endothelial, and coronary effects of nicotine. Clin. Exp. Pharmacol. Physiol. 2008, 35:458-463.
2. al'Absi M. Hypothalamic-pituitary-adrenocortical responses to psychological stress and risk for smoking relapse. Int. J. Psychophysiol. 2006, 59(3):218-227.
3. al'Absi M., Amunrud T., Wittmers L.E. Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers. Pharmacol. Biochem. Behav. 2002, 72(3):707-716.
4. al'Absi M., Hatsukami D., Davis G.L. Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse. Psychopharmacology (Berl.) 2005, 181(1):107-117.
5. al'Absi M., Wittmers L.E., Erickson J., Hatsukami D., Crouse B. Attenuated adrenocortical and blood pressure responses to psychological stress in ad libitum and abstinent smokers. Pharmacol. Biochem. Behav. 2003, 74(2):401-410.
6. Acharya U.R., Joseph K.P., Kannathal N., Lim C.M., Suri J.S. Heart rate variability: a review. Med. Biol. Eng. Comput. 2006, 44:1031-1051.
7. Back S.E., Waldrop A.E., Saladin M.E., Yeatts S.D., Simpson A., McRae A.L., et al. Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology 2008, 33(5):560-568.
8. Baron J.A., Comi R.J., Cryns V., Brinck-Johnsen T., Mercer N.G. The effect of cigarette smoking on adrenal cortical hormones. J. Pharmacol. Exp. Ther. 1995, 272(1):151-155.
9. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005, 8:1458-1463.
10. Benwell M.E., Balfour D.J. Effects of chronic nicotine administration on the response and adaptation to stress. Psychopharmacology (Berl.) 1982, 76(2):160-162.
11. Borrelli B., Papandonatos G., Spring B., Hitsman B., Niaura R. Experimenter-defined quit dates for smoking cessation: adherence improves outcomes for women but not for men. Addiction 2004, 99(3):378-385.
12. Brady K.T., McRae A.L., Moran-Santa Maria M.M., DeSantis S.M., Simpson A.N., Waldrop A.E., et al. Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. Arch. Gen. Psychiatry 2009, 66(4):422-430.
13. Buchmann A.F., Laucht M., Schmid B., Wiedemann K., Mann K., Zimmermann U.S. Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol. 2010, 24(2):247-255.
14. Caggiula A.R., Donny E.C., Epstein L.H., Sved A.F., Knopf S., Rose C., et al. The role of corticosteroids in nicotine's physiological and behavioral effects. Psychoneuroendocrinology 1998, 23(2):143-159.
15. Cam G.R., Bassett J.R. Effect of prolonged exposure to nicotine and stress on the pituitary-adrenocortical response; the possibility of cross-adaptation. Pharmacol. Biochem. Behav. 1984, 20(2):221-226.
16. Canals J., Colomina M.T., Gallart I., Domingo J.L. Stressful events and salivary cortisol. Psychol. Rep. 1997, 80(1):305-306.
17. CDC Cigarette smoking among adults - United States, 2007. MMWR 2007, 57:1221-1226.
18. CDC Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR 2008, 45:1226-1228.
19. Cherek D.R. Effects of acute exposure to increased levels of background industrial noise on cigarette smoking behavior. Int. Arch. Occup. Environ. Health 1985, 56(1):23-30.
20. Chida Y., Hamer M. Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: a quantitative review of 30 years of investigations. Psychol. Bull. 2008, 134:829-885.
21. Childs E., de Wit H. Hormonal, cardiovascular, and subjective responses to acute stress in smokers. Psychopharmacology (Berl.) 2009, 203(1):1-12.
22. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorders. JAMA 1992, 267(9):1244-1252.
23. Cohen S., Lichtenstein E. Perceived stress, quitting smoking, and smoking relapse. Health Psychol. 1990, 9(4):466-478.
24. Conger J.J. Alcoholism: theory, problem and challenge. II. Reinforcement theory and the dynamics of alcoholism. Q. J. Stud. Alcohol 1956, 17(2):296-305.
25. Corrigall W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl.) 1992, 107(2-3):285-289.
26. Cryer P., Haymond M., Santiago J., Shah S. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N. Engl. J. Med. 1976, 295:573-577.
27. Cummings K.M., Jaen C.R., Giovino G. Circumstances surrounding relapse in a group of recent exsmokers. Prev. Med. 1985, 14(2):195-202.
28. Davis M.C., Matthews K.A. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress. Health Psychol. 1990, 9(6):717-736.
29. del Arbol J.L., Munoz J.R., Ojeda L., Cascales A.L., Irles J.R., Miranda M.T., et al. Plasma concentrations of beta-endorphin in smokers who consume different numbers of cigarettes per day. Pharmacol. Biochem. Behav. 2000, 67(1):25-28.
30. Dembroski T.M., MacDougall J.M., Cardozo S.R., Ireland S.K., Krug-Fite J. Selective cardiovascular effects of stress and cigarette smoking in young women. Health Psychol. 1985, 4(2):153-167.
31. de Wit H., Vicini L., Childs E., Sayla M.A., Terner J. Does stress reactivity or response to amphetamine predict smoking progression in young adults? A preliminary study. Pharmacol. Biochem. Behav. 2007, 86:312-319.
32. Di Chiara G., Imperato A. Drugs of abuse preferentially stimulate dopaminerelease in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:5274-5278.
33. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 2004, 130(3):355-391.
34. Dunn A. Stress related activation of cerebral dopaminergic systems. Ann. N. Y. Acad. Sci. 1988, 537:188-205.
35. Epstein L.H., Collins F.L. The measurement of situational influences of smoking. Addict. Behav. 1977, 2(1):47-53.
36. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
37. Fagan Z.M., Mansvelder H.D., Keath J.R., McGehee D.S. Short- and long-term modulation of synaptic inputs to brain reward areas by nicotine. Ann. N. Y. Acad. Sci. 2003, 1003:185-195.
38. Falba T., Teng H.M., Sindelar J.L., Gallo W.T. The effect of involuntary job loss on smoking intensity and relapse. Addiction 2005, 100(9):1330-1339.
39. Field A.E., Colditz G.A., Willett W.C., Longcope C., McKinlay J.B. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J. Clin. Endocrinol. Metab. 1994, 79(5):1310-1316.
40. Frederick S.L., Reus V.I., Ginsberg D., Hall S.M., Munoz R.F., Ellman G. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol. Psychiatry 1998, 43(7):525-530.
41. Fuxe K., Andersson K., Eneroth P., Harfstrand A., Agnati L.F. Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical implications. Psychoneuroendocrinology 1989, 14:19-41.
42. Gallagher D., Terenzi T., de Meersman R. Heart rate variability in smokers, sedentary and aerobically fit individuals. Clin. Auton. Res. 1992, 2:383-387.
43. Gentry C.L., Lukas R.J. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr. Drug Targets CNS Neurol. Disord. 2002, 1:359-385.
44. Gilbert D.G., Dibb W.M., Plath L.C., Hiyane S.G. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance. Psychophysiology 2000, 37:583-595.
45. Gilbert D.G., Meliska C.J., Williams C.L., Jensen R.A. Subjective correlates of cigarette-smoking induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology (Berl.) 1992, 106:275-281.
46. Gilbert D.G., Meliska C.J., Plath L.C. Noise stress does not modulate effects of smoking/nicotine on beta-endorphin, cortisol, ACTH, glucose, and mood. Psychopharmacology (Berl.) 1997, 130(3):197-202.
47. Glassman A.H., Stetner F., Walsh B.T., Raizman P.S., Fleiss J.L., Cooper T.B., et al. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 1988, 259(19):2863-2866.
48. Glassman A.H., Covey L.S., Dalack G.W., Stetner F., Rivelli S.K., Fleiss J., et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin. Pharmacol. Ther. 1993, 54(6):670-679.
49. Goeders N.E., Guerin G.F. Role for corticosterone in intravenous cocaine self-administration in rats. Neuroendocrinology 1996, 64:337-348.
50. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 2002, 159:1642-1652.
51. Grassi G., Seravalle G., Calhoun D.A., Bolla G.B., Giannattasio C., Marabini M., Del Bo A., Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994, 90:248-253.
52. Haass M., Kubler W. Nicotine and sympathetic neurotransmission. Cardiovasc. Drugs Ther. 1997, 10:657-665.
53. Hall W. What have population surveys revealed about substance use disorders and their co-morbidity with other mental disorders?. Drug Alcohol Rev. 1996, 15(2):157-170.
54. Hayano J., Yamada M., Sakakibara Y., Fujinami T., Yokoyama K., Watanabe Y., et al. Short- and long-term effects of cigarette smoking on heart rate variability. Am. J. Cardiol. 1990, 65:84-88.
55. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000, 284(5):592-597.
56. Heishman S.J. Behavioral and cognitive effects of smoking: relationship to nicotine addiction. Nicotine Tob. Res. 1999, 1(Suppl 2):143-147. (discussion S165-146).
57. Hering D., Kucharska W., Kara T., Somers V.K., Narkiewicz K. Smoking is associated with chronic sympathetic activation in hypertension. Blood Press. 2010, 19(3):152-155.
58. Hymowitz N., Sexton M., Ockene J., Grandits G. Baseline factors associated with smoking cessation and relapse. MRFIT Research Group. Prev. Med. 1991, 20(5):590-601.
59. Jensen E.W., Espersen K., Kanstrup L.-L., Christensen N.J. Plasma noradrenaline and ageing: effects of smoking habits. Eur. J. Clin. Invest. 1996, 26(10):839-846.
60. Kalivas P.W., Duffy P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol. Psychiatry 1989, 25(7):913-928.
61. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am. J. Psychiatry 1985, 142(11):1259-1264.
62. Kirschbaum C., Wust S., Strasburger C.J. 'Normal' cigarette smoking increases free cortisol in habitual smokers. Life Sci. 1992, 50(6):435-442.
63. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28(1-2):76-81.
64. Kirschbaum C., Strasburger C.J., Langkrar J. Attenuated cortisol response to psychological stress but not to CRH or ergometry in young habitual smokers. Pharmacol. Biochem. Behav. 1993, 44(3):527-531.
65. Kirschbaum C., Scherer G., Strasburger C.J. Pituitary and adrenal hormone responses to pharmacological, physical, and psychological stimulation in habitual smokers and nonsmokers. Clin. Investig. 1994, 72(10):804-810.
66. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 1999, 61(2):154-162.
67. Kizildere S., Gluck T., Zietz B., Schomerich J., Straub R.H. During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH. Eur. J. Endocrinol. 2003, 148(1):45-53.
68. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278(5335):52-58.
69. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24(2):97-129.
70. Koob G.F., Le Moal M. Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. Roy. Soc. London Ser. B, Biol. Sci. 2008, 363:3113-3123.
71. Kudielka B.M., Buske-Kirschbaum A., Hellhammer D.H., Kirschbaum C. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 2004, 29(1):83-98.
72. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69(1):113-132.
73. Kumsta R., Entringer S., Koper J.W., van Rossum E.F., Hellhammer D.H., Wust S. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol. Psychiatry 2007, 62(8):863-869.
74. Kupari M., Virolainen J., Koskinen P., Tikkanen M.J. Short-term heart rate variability and factors modifying the risk of coronary artery diseasein a population sample. Am. J. Cardiol. 1993, 72(12):897-903.
75. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284(20):2606-2610.
76. Leventhal H., Cleary P.D. The smoking problem: a review of the research and theory in behavioral risk modification. Psychol. Bull. 1980, 88(2):370-405.
77. Li L., Power C., Kelly S., Kirschbaum C., Hertzman C. Life-time socio-economic position and cortisol patterns in mid-life. Psychoneuroendocrinology 2007, 32(7):824-833.
78. Li C.R., Sinha R. Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction. Neurosci. Biobehav. Rev. 2008, 32(3):581-597.
79. Lindheim S.R, Legro R.S., Bernstein L., Stanczyk F.Z., Vijod M.A., Presser S.C., et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am. J. Obstet. Gynecol. 1992, 167(6):1831-1836.
80. Lovallo W.R. Cortisol secretion patterns in addiction and addiction risk. Int. J. Psychophysiol. 2006, 59(3):195-202.
81. MacDougall J.M., Musante L., Howard J.A., Hanes R.L., Dembroski T.M. Individual differences in cardiovascular reactions to stress and cigarette smoking. Health Psychol. 1986, 5(6):531-544.
82. Mangan G.L., Golding J.F. The Psychopharmacology of Smoking 1984, Cambridge University Press, Cambridge, UK.
83. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors 1985, Guilford Press, New York. G.A. Marlatt, J.R. Gordon (Eds.).
84. Matheny K.B., Weatherman K.E. Predictors of smoking cessation and maintenance. J. Clin. Psychol. 1998, 54(2):223-235.
85. Matta S.G., Fu Y., Valentine J.D., Sharp B.M. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998, 23:103-113.
86. McCabe R.E., Chudzik S.M., Antony M.M., Young L., Swinson R.P., Zolvensky M.J. Smoking behaviors across anxiety disorders. J. Anxiety Disord. 2004, 18(1):7-18.
87. McEwen A., West R., McRobbie H. Motives for smoking and their correlates in clients attending stop smoking treatment services. Nicotine Tob. Res. 2008, 10(5):843-850.
88. McEwen B.S., Weiss J.M., Schwartz L.S. Selective retention of corticosterone by limbic structures in rat brain. Nature 1968, 220:911-912.
89. McKee S., Sinha R., Weinberger A.H., Sofuoglu M., Harrison E.L., Lavery M., et al. Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J. Psychopharmacol. 2011, 25(4):490-502.
90. Meliska C.J., Gilbert D. Hormonal and subjective effects of smoking the first five cigarettes of the day: a comparison in males and females. Pharmacol. Biochem. Behav. 1991, 40:229-235.
91. Mendelson J.H., Goletiani N., Sholar M.B., Siegel A., Mello N. Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 2008, 33:749-760.
92. Mendelson J.H., Sholar M.B., Goletiani N., Siegel A., Mello N. Effects of low- and high-nicotine cigarette smoking on mood states and HPA axis in men. Neuropsychopharmacology 2005, 30:1751-1763.
93. Minami J., Ishimitsu T., Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999, 33:586-590.
94. Moss H.B., Vanyukov M., Yao J.K., Kirillova G.P. Salivary cortisol responses in prepubertal boys: the effects of parental substance abuse and association with drug use behavior during adolescence. Biol. Psychiatry 1999, 45(10):1293-1299.
95. Moss H.B., Vanyukov M.M., Martin C.S. Salivary cortisol responses and the risk for substance abuse in prepubertal boys. Biol. Psychiatry 1995, 38(8):547-555.
96. Najem B., Houssiere A., Pathak A., Janssen C., Lemogoum D., Xhaet O., et al. Acute cardiovascular and sympathetic effects of nicotine replacement therapy. Hypertension 2006, 47:1162-1167.
97. Narkiewicz K., van de Borne P.J.H., Hausberg M., Cooley R.L., Winniford M.D., Davison D.E., Somers V.K. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998, 98:528-534.
98. Newhouse P.A., Sunderland T., Narang P.K., Mellow A.M., Fertig J.B., Lawlor B.A., Murphy D.L. Neuroendocrine, physiologic and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease. Psychoneuroendocrinology 1990, 15:471-484.
99. Newport D.J., Heim C., Bonsall R., Miller A.H., Nemeroff C.B. Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol. Psychiatry 2004, 55(1):10-20.
100. Niedermaier O.N., Smith M.L., Beightol L.A., Zukowska-Grojec Z., Goldstein D.S., Eckberg D.L. Influence of cigarette smoking on human autonomic function. Circulation 1993, 88:562-571.
101. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 1994, 16(1):36-44.
102. Nisell M., Nomikos G.G., Svensson T.H. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol. Toxicol. 1995, 76(3):157-162.
103. O'Connell K.A., Martin E.J. Highly tempting situations associated with abstinence, temporary lapse, and relapse among participants in smoking cessation programs. J. Consult. Clin. Psychol. 1987, 55(3):367-371.
104. Ockenfels M.C., Porter L., Smyth J., Kirschbaum C., Hellhammer D.H., Stone A.A. Effect of chronic stress associated with unemployment on salivary cortisol: overall cortisol levels, diurnal rhythm, and acute stress reactivity. Psychosom. Med. 1995, 57(5):460-467.
105. Olff M., Meewisse M.L., Kleber R.J., van der Velden P.G., Drogendijk A.N., van Amsterdam J.G., et al. Tobacco usage interacts with postdisaster psychopathology on circadian salivary cortisol. Int. J. Psychophysiol. 2006, 59(3):251-258.
106. Parrott A.C. Cigarette smoking: effects upon self-rated stress and arousal over the day. Addict. Behav. 1993, 18(4):389-395.
107. Parrott A.C. Smoking cessation leads to reduced stress, but why?. Int. J. Addict. 1995, 30(11):1509-1516.
108. Payne T.J., Schare M.L., Levis D.J., Colletti G. Exposure to smoking-relevant cues: effects on desire to smoke and topographical components of smoking behavior. Addict. Behav. 1991, 16(6):467-479.
109. Perkins K.A., Epstein L.H., Jennings J.R., Stiller R. The cardiovascular effects of nicotine during stress. Psychopharmacology (Berl.) 1986, 90(3):373-378.
110. Perkins K.A., Grobe J.E. Increased desire to smoke during acute stress. Br. J. Addict. 1992, 87(7):1037-1040.
111. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245(4925):1511-1513.
112. Piazza P.V., Deminiere J.M., le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 1990, 514(1):22-26.
113. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. U.S.A. 1991, 88(6):2088-2092.
114. Piazza P.V., Derouche V., Rouge-Pont F., Le Moal M. Behavioral and biological factors associated with individual vulnerability to psychostimulant abuse. NIDA Res. Monogr. 1998, 169:105-133.
115. Piazza P.V, Le Moal M.L. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. Toxicol. 1996, 36:359-378.
116. Pomerleau C.S., Pomerleau O.F. The effects of a psychological stressor on cigarette smoking and subsequent behavioral and physiological responses. Psychophysiology 1987, 24(3):278-285.
117. Pomerleau O.F., Pomerleau C.S. Cortisol response to a psychological stressor and/or nicotine. Pharmacol. Biochem. Behav. 1990, 36(1):211-213.
118. Pomerleau O.F., Pomerleau C.S., Snedecor S.M., Gaulrapp S., Brouwer R.N., Cameron O.G. Depression, smoking abstinence and HPA function in women smokers. Hum. Psychopharmacol. 2004, 19(7):467-476.
119. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996, 382:255-257.
120. Pope C.A., Eatough D.J., Gold D.R., Pang Y., Nielsen K.R., Nath P., et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ. Health Perspect. 2001, 109(7):711-716.
121. Prasad B., Sorg B., Ulibarri C., Kalivas P. Sensitization to stress and psychostimulants: involvement of dopamine transmission versus the HPA axis. Ann. N. Y. Acad. Sci. 1995, 771:617-625.
122. Rao U., Hammen C.L., London E.D., Poland R.E. Contribution of hypothalamic-pituitary-adrenal activity and environmental stress to vulnerability for smoking in adolescents. Neuropsychopharmacology 2009, 34:2721-2732.
123. Roberts D.C.S., Koob G.F., Klonoff P., Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 1980, 12L:781-787.
124. Rohleder N., Kirschbaum C. The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int. J. Psychophysiol. 2006, 59(3):236-243.
125. Rohleder N., Schommer N.C., Hellhammer D.H., Engel R., Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom. Med. 2001, 63(6):966-972.
126. Rose J.E., Ananda S., Jarvik M.E. Cigarette smoking during anxiety-provoking and monotonous tasks. Addict. Behav. 1983, 8(4):353-359.
127. Rosencrans J.A., Karin L.D. Effects of nicotine on the hypothalamic-pituitary-axis (HPA) and immune function: introduction to the Sixth Nicotine Round Table Satellite, American Society of Addiction Medicine Nicotine Dependence Meeting, November 15, 1997. Psychoneuroendocrinology 1998, 23:95-102.
128. Roy M.P., Steptoe A., Kirschbaum C. Association between smoking status and cardiovascular and cortisol stress responsivity in healthy young men. Int. J. Behav. Med. 1994, 1(3):264-283.
129. Russell J.A., Mehrabian A. The mediating role of emotions in alchol use. J. Stud. Alcohol 1975, 36:1508-1536.
130. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J. Neurosci. 2000, 20:4657-4668.
131. Schachter S., Silverstein B., Perlick D. 5. Psychological and pharmacological explanations of smoking under stress. J. Exp. Psychol. Gen. 1977, 106(1):31-40.
132. Schuetze P., Lopez F.A., Granger D.A., Eiden R.D. The association between prenatal exposure to cigarettes and cortisol reactivity and regulation in 7-month-old infants. Dev. Psychobiol. 2008, 50(8):819-834.
133. Seeman T.E., Singer B., Wilkinson C.W., McEwen B. Gender differences in age-related changes in HPA axis reactivity. Psychoneuroendocrinology 2001, 26(3):225-240.
134. Selye H. Thymus and adrenals in the response of the organism to injuries and intoxications, British. J. Exp. Pathol. 1936, 17:234-248.
135. Seyler L.E., Fertig J.B., Pomerleau O.F., Hunt D., Parker K. The effects of smoking on ACTH and cortisol secretion. Life Sci. 1984, 34:57-65.
136. Sher K.J., Levenson R.W. Risk for alcoholism and individual differences in the stress-response-dampening effect of alcohol. J. Abnorm. Psychol. 1982, 91(5):350-367.
137. Sherman S.E., Fu S.S., Joseph A.M., Lanto A.B., Yano E.M. Gender differences in smoking cessation services received among veterans. Womens Health Issues 2005, 15(3):126-133.
138. Shiffman S. Relapse following smoking cessation: a situational analysis. J. Consult. Clin. Psychol. 1982, 50(1):71-86.
139. Shiffman S., Hickcox M., Paty J.A., Gnys M., Kassel J.D., Richards T.J. Progression from a smoking lapse to relapse: prediction from abstinence violation effects, nicotine dependence, and lapse characteristics. J. Consult. Clin. Psychol. 1996, 64(5):993-1002.
140. Siahpush M., Carlin J.B. Financial stress, smoking cessation and relapse: results from a prospective study of an Australian national sample. Addiction 2006, 101(1):121-127.
141. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl.) 2001, 158(4):343-359.
142. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Ann. N. Y. Acad. Sci. 2008, 1141:105-130.
143. Sinha R., Fox H.C., Hong K.A., Bergquist K., Bhagwagar Z., Siedlarz K.M. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 2009, 34(5):1198-1208.
144. Solomon R.L. Addiction: an opponent-process theory of acquired motivation: the affective dynamics of addiction. Psychopathology: Experimental Models 1977, 66-103. W H Freeman/Times Books/Henry Holt & Co, New York. J.D. Maser, M.E.P. Seligman (Eds.).
145. Swan G.E., Denk C.E., Parker S.D., Carmelli D., Furze C.T., Rosenman R.H. Risk factors for late relapse in male and female ex-smokers. Addict. Behav. 1988, 13(3):253-266.
146. Taylor J.R., Robbins T.W. Enhanced behavioral control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl.) 1984, 84:405-412.
147. Tersman Z., Collins A., Eneroth P. Cardiovascular responses to psychological and physiological stressors during the menstrual cycle. Psychosom. Med. 1991, 53(2):185-197.
148. Thierry A.M., Tassin J.P., Blanc G., Glowinski J. Selective activation of the mesocortical dopamine system by stress. Nature 1976, 263:242-244.
149. Tomkins S.S. Psychological model for smoking behavior. Am. J. Public Health Nations Health 1966, Suppl 56(12):17-20.
150. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53(4):865-871.
151. Tsoh J.Y., Humfleet G.L., Munoz R.F., Reus V.I., Hartz D.T., Hall S.M. Development of major depression after treatment for smoking cessation. Am. J. Psychiatry 2000, 157(3):368-374.
152. Tsuji H., Venditti F.J., Manders E.S., Evans J.C., Larson M.G., Feldman C.L., et al. Determinants of heart rate variability. J. Am. Coll. Cardiol. 1996, 28:1539-1546.
153. Turner C.F., Ku L., Rogers S.M., Lindberg L.D., Pleck J.H., Sonenstein F.L. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science 1998, 280(5365):867-873.
154. Uhart M., McCaul M.E., Oswald L.M., Choi L., Wand G.S. GABRA6 gene polymorphism and an attenuated stress response. Mol. Psychiatry 2004, 9(11):998-1006.
155. Vanyukov M.M., Moss H.B., Plail J.A., Blackson T., Mezzich A.C., Tarter R.E. Antisocial symptoms in preadolescent boys and in their parents: associations with cortisol. Psychiatry Res. 1993, 46(1):9-17.
156. Virkkunen M. Urinary free cortisol secretion in habitually violent offenders. Acta Psychiatr. Scand. 1985, 72(1):40-44.
157. Volkow N.D., Fowler J.S., Wang G.-J. The addicted human brain viewed in light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004, 47(Suppl. 1):3-13.
158. Weber C., Thayer J., Rudat M., Wirtz P., Zimmermann-Viehoff F., Thomas A., et al. Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers. Eur. J. Appl. Physiol. 2010, 109:201-211.
159. Wewers M.E. The role of postcessation factors in tobacco abstinence: stressful events and coping responses. Addict. Behav. 1988, 13(3):297-302.
160. Wikler A. Recent progress in research on the neurophysiologic basis of morphine addiction. Am. J. Psychiatry 1948, 105(5):329-338.
161. Wileyto E.P., Patterson F., Niaura R., Epstein L.H., Brown R.A., Audrain-McGovern J., et al. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine Tob. Res. 2005, 7(2):257-268.
162. Wills T.A., Sandy J.M., Yaeger A.M. Stress and smoking in adolescence: a test of directional hypotheses. Health Psychol. 2002, 21(2):122-130.
163. Wills T.A., Shiffman S. Coping and substance abuse: a conceptual framework. Coping and Substance Use 1985, 3-24. Academic Press, Orlando. S. Shiffman, T.A. Wills (Eds.).
164. Wills T.A., Vaccaro D., McNamara G., Hirky A.E. Escalated substance use: a longitudinal grouping analysis from early to middle adolescence. J. Abnorm. Psychol. 1996, 105(2):166-180.
165. Winternitz W.W., Quillen D. Acute hormonal response to cigarette smoking. J. Clin. Pharmacol. 1977, 17:389-397.
166. Wolf O.T., Schommer N.C., Hellhammer D.H., McEwen B.S., Kirschbaum C. The relationship between stress induced cortisol levels and memory differs between men and women. Psychoneuroendocrinology 2001, 26(7):711-720.
167. Yehuda R., Halligan S.L., Bierer L.M. Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child. Psychoneuroendocrinology 2002, 27(1-2):171-180.
168. Yotsukura M., Koide Y., Fujii K., Tomono Y., Katayama A., Ando H., et al. Heart rate variability during the first month of smoking cessation. Am. Heart J. 1998, 135:1004-1009.
169. Young E.A., Abelson J.L., Cameron O.G. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man. Psychoneuroendocrinology 2005, 30(8):807-814.
170. Zeskind P.S., Gingras J.L. Maternal cigarette-smoking during pregnancy disrupts rhythms in fetal heart rate. J. Pediatr. Psychol. 2006, 31(1):5-14.